These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9784827)

  • 21. Audiologic and vestibular findings in a sample of human immunodeficiency virus type-1-infected Mexican children under highly active antiretroviral therapy.
    Palacios GC; Montalvo MS; Fraire MI; Leon E; Alvarez MT; Solorzano F
    Int J Pediatr Otorhinolaryngol; 2008 Nov; 72(11):1671-81. PubMed ID: 18814921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Correlation between mantoux and tuberculin's fraction from delayed hypersensitivity skin test, in a cohort from HIV-1 positive patients, in function of immunodeficiency level, and active tuberculosis incidence].
    Cabarcos Ortiz de Barrón A; Barrio Gómez E; Lado Lado FL; Rodríguez López I; Lorenzo Zúñiga V
    An Med Interna; 2000 Dec; 17(12):632-6. PubMed ID: 11213577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.
    Jacobson JM; Lederman MM; Spritzler J; Valdez H; Tebas P; Skowron G; Wang R; Jackson JB; Fox L; Landay A; Gilbert MJ; O'Neil D; Bancroft L; Al-Harthi L; Jacobson MA; Merigan TC; Glesby MJ;
    J Infect Dis; 2003 Dec; 188(12):1804-14. PubMed ID: 14673758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus.
    Sirikwin S; Likanonsakul S; Waradejwinyoo S; Pattamadilok S; Kumperasart S; Chaovavanich A; Manatsathit S; Malerczyk C; Wasi C
    Vaccine; 2009 Jul; 27(32):4350-4. PubMed ID: 19487057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morbidity that is associated with curettage for the management of spontaneous and induced abortion in women who are infected with HIV.
    Stuart GS; Sheffield JS; Hill JB; McIntire DD; McElwee B; Wendel GD
    Am J Obstet Gynecol; 2004 Sep; 191(3):993-7. PubMed ID: 15467578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.
    Hulgan T; Raffanti S; Kheshti A; Blackwell RB; Rebeiro PF; Barkanic G; Ritz B; Sterling TR
    J Infect Dis; 2005 Sep; 192(6):950-7. PubMed ID: 16107946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients.
    Raszka WV; Moriarty RA; Ottolini MG; Waecker NJ; Ascher DP; Cieslak TJ; Fischer GW; Robb ML
    J Pediatr; 1996 Aug; 129(2):245-50. PubMed ID: 8765622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical usefulness of Multitest in the evaluation of cellular immunity].
    Feijoó RM; Ardiles A; Lemp P; King A; Villamán JJ; Parra A; Silva M
    Rev Med Chil; 1996 Mar; 124(3):327-36. PubMed ID: 9008945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Horberg MA; Hurley LB; Klein DB; Follansbee SE; Quesenberry C; Flamm JA; Green GM; Luu T
    Arch Surg; 2006 Dec; 141(12):1238-45. PubMed ID: 17178967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed-type hypersensitivity anergy in human immunodeficiency virus-infected persons screened for infection with Mycobacterium tuberculosis.
    Huebner RE; Schein MF; Hall CA; Barnes SA
    Clin Infect Dis; 1994 Jul; 19(1):26-32. PubMed ID: 7948554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of the lymphocyte proliferation test with phytohemagglutinin in the immune evaluation of Brazilian HIV-infected patients.
    Casseb JS; Benard G; Saito R; Brígido LF; Tanaami D; Joaquim ES; Duarte AJ
    J Investig Allergol Clin Immunol; 1995; 5(6):347-9. PubMed ID: 8653224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed hypersensitivity skin testing and anergy in a population of gay men.
    Sears SD; Fox R; Brookmeyer R; Leavitt R; Polk BF
    Clin Immunol Immunopathol; 1987 Nov; 45(2):177-83. PubMed ID: 2822314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed-type hypersensitivity testing in Tanzanian adults with HIV infection.
    Miller WC; Thielman NM; Swai N; Cegielski JP; Shao J; Ting D; Mlalasi J; Manyenga D; Lallinger GJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul; 12(3):303-8. PubMed ID: 8673536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of anergy in human immunodeficiency virus-infected adolescents and the association of delayed-type hypersensitivity with subject characteristics.
    Smith Rogers A; Ellenberg JH; Douglas SD; Henry-Reid L; Peralta L; Wilson CM
    J Adolesc Health; 2000 Dec; 27(6):384-90. PubMed ID: 11090740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic utility of delayed-type hypersensitivity skin testing in the evaluation of HIV-infected patients. Military Medical Consortium for Applied Retroviral Research.
    Birx DL; Brundage J; Larson K; Engler R; Smith L; Squire E; Carpenter G; Sullivan M; Rhoads J; Oster C
    J Acquir Immune Defic Syndr (1988); 1993 Nov; 6(11):1248-57. PubMed ID: 7901383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type 1 infection is associated with T cell nonresponsiveness in vitro.
    Maas JJ; Roos MT; Keet IP; Mensen EA; Krol A; Veenstra J; Schellekens PT; Jurriaans S; Coutinho RA; Miedema F
    J Infect Dis; 1998 Oct; 178(4):1024-9. PubMed ID: 9806030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus status and delayed-type hypersensitivity skin testing in Ugandan children.
    Mandalakas AM; Guay L; Musoke P; Carroll-Pankhurst C; Olness KN
    Pediatrics; 1999 Feb; 103(2):E21. PubMed ID: 9925867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed type hypersensitivity testing in surgical patients.
    MacLean LD
    Surg Gynecol Obstet; 1988 Mar; 166(3):285-93. PubMed ID: 3278396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.